Follow us Facebook Icon


23 January, 2021

South African regulator approves Serum Institute's Covishield days before receiving vaccine

Battling the second wave of Covid-19, South Africa is expected to receive a million doses of Covishield by the end of January and another 5 lakh in February of this year...Read more...

18 January, 2021

Serum Institute’s Covishield vaccine may be recommended for international use

AstraZeneca is engaging with governments, multilateral organisations and other partners around the world for broad and equitable access...Read more...

Cyrus Poonawalla

Dr. Cyrus S. Poonawalla

Chairman and Managing Director
Mr. Adar C. Poonawalla

Mr. Adar C. Poonawalla

Natasha Poonawalla

Mrs. Natasha A. Poonawalla

Executive Director - Serum Instiute of India
Chairperson - Villoo Poonawalla Foundation


Poonawalla Group

The Cyrus Poonawalla Group of Companies headquartered in Pune, India are a diversified group with business interests that include Pharmaceuticals & Biotechnology, Finance, Clean Energy, Hospitality & Realty and Aviation.